Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.5260
+0.0260 (5.20%)
At close: Sep 3, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 13.64 million as of September 3, 2026. Its market cap has decreased by -50.62% in one year.
Market Cap
13.64M
Enterprise Value
11.92M
Revenue
-537.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
ChartMarket Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 13.64M, a decrease of -73.31%. That is a compound annual growth rate of -10.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 13.64M | -43.19% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Modus Therapeutics Holding AB | 69.74M |
| Pila Pharma AB | 67.61M |
| OncoZenge AB | 65.53M |
| AcouSort AB | 63.07M |
| Fluicell AB | 42.17M |
| ExpreS2ion Biotech Holding AB | 33.60M |
| Alligator Bioscience AB | 16.58M |
| NanoEcho AB | 13.18M |